. 2022 Nov 23;8(47):eade4433. doi: 10.1126/sciadv.ade4433
Copyright © 2022 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution License 4.0 (CC BY).
This is an open-access article distributed under the terms of the Creative Commons Attribution license, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Fig. 1. Study schema.
Vaccine groups and timing of immunization and challenge are shown.